Epidermal growth factor receptor

临床试验

计划入组 44 人 · 首次发布于 2024 年 8 月 9 日

已完成

NCT06606301

IMMUNOHISTOCHEMICAL EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTOR

计划入组 61 人 · 首次发布于 2024 年 9 月 23 日

撤回

NCT02297425

A Study For Patients With EGFRm (Epidermal Growth Factor Receptor Mutant) Lung Cancer

首次发布于 2014 年 11 月 21 日

药物

查看全部 2282 →

epidermal growth factor receptor binding sdAb (imaging agent)

Biotech

Investigational

Epidermal Growth Factor Receptor variant III (EGFRvIII) chimeric antigen receptor T cells

Biotech

Investigational

DF-1001

机构

查看全部 98 →

Zymeworks

Canada

Veru Inc

United States

Arvinas Estrogen Receptor, Inc.

United States

资讯

查看全部 12342 →

5年前

FDA Grants Fast Track Designation to Panitumumab for Metastatic Colorectal Cancer Treatment

去年

Genor Biopharma Secures NMPA Approval for Lerociclib CDK4/6 Inhibitor in Advanced Breast Cancer

去年

临床试验

Epidermal Growth Factor Receptor Inhibition for Keratinopathies

IMMUNOHISTOCHEMICAL EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTOR

A Study For Patients With EGFRm (Epidermal Growth Factor Receptor Mutant) Lung Cancer

药物

epidermal growth factor receptor binding sdAb (imaging agent)

Epidermal Growth Factor Receptor variant III (EGFRvIII) chimeric antigen receptor T cells

DF-1001

机构

Zymeworks

Veru Inc

Arvinas Estrogen Receptor, Inc.

资讯

FDA Grants Fast Track Designation to Panitumumab for Metastatic Colorectal Cancer Treatment

Genor Biopharma Secures NMPA Approval for Lerociclib CDK4/6 Inhibitor in Advanced Breast Cancer

Roche's Itovebi Demonstrates Overall Survival Benefit in PIK3CA-Mutated Breast Cancer